Post-COVID-19 Intestinal and Mesenteric Mucormycosis

2Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A thirty-eight-year-old uncontrolled diabetic with a recent COVID-19 infection presented with extensive bowel ischemia and gangrene with a microscopic diagnosis of intestinal and mesenteric mucormycosis. Although there are a few reported cases of primary gastrointestinal mucormycosis, our case showing involvement of the intestine and/or mesentery, that too in a post-COVID patient, is quite uncommon. The immunosuppressive effect of the COVID-19 disease, uncontrolled diabetes, and the use of corticosteroids for the treatment of severe COVID are the most probable reasons for the emergence of severe opportunistic infections, both as a coinfection and as a sequalae to COVID.

Cite

CITATION STYLE

APA

Banerjee, N., Lodha, M., Kompally, P., & Chawla, S. (2023). Post-COVID-19 Intestinal and Mesenteric Mucormycosis. American Surgeon, 89(6), 2770–2773. https://doi.org/10.1177/00031348211048841

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free